Advertisement

Psychopharmacology

, Volume 108, Issue 1–2, pp 47–50 | Cite as

5-HT1A receptor agonists prevent in rats the yawning and penile erections induced by direct dopamine agonists

  • P. Simon
  • B. Guardiola
  • J. Bizot-Espiard
  • P. Schiavi
  • J. Costentin
Original Investigations

Abstract

The new compound (+) S-20499, an amino chromane derivative (8[-4[N-(5-methoxychromane-3yl)N-propyl]aminobutyl] azaspiro[4–5] décane-7,9 dione), is a high affinity full 5-HT1A agonist. We have investigated its effects on dopaminergic transmission. (+) S-20499 displayed a 10−8 M affinity for D2 dopamine (DA) receptors, 100 fold lower than for 5-HT1A receptors. The hypothermic effect of the drug was reversed by haloperidol in mice, suggesting that it behaves as a direct dopamine agonist. However, increasing doses of (+) S-20499 induced neither yawning nor penile erections, which constitute characteristic responses of direct DA agonists administered at low doses. In addition, (+) S-20499 prevented the apomorphine (100 µg/kg SC) induced yawning and penile erections. This inhibition appears to result from the stimulation of 5-HT1A receptors since it is an effect shared by both buspirone (from 5 mg/kg) and 8-OH-DPAT (from 0.10 mg/kg). In addition, when rats are treated with the 5-HT1A receptor antagonist tertatolol (2–5 mg/kg; SC), increasing doses of (+) S-20499 elicit the expected yawns and penile erections. It is concluded that the 5-HT1A agonist property opposes to that of D2 dopamine receptor stimulation with regard to yawning and penile erections.

Key words

Yawning Penile erections (+) S-20499 5-HT1A agonists D2 receptors Apomorphine Rat 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Arvidsson LE, Hacksell U, Nilsson JLG, Hjorth S, Carlsson A, Lindberg P, Sanchez D, Wickstrom H (1981) 8-Hydroxy-2-(di-n-propylamino) tetralin, a new centrally acting 5-HT receptor agonist. J Med Chem 24:921–923CrossRefPubMedGoogle Scholar
  2. Benloucif S, Galloway P (1991) Facilitation of dopamine release in vivo by serotonin agonists: studies with microdialysis. Eur J Pharmacol 200:1–8CrossRefPubMedGoogle Scholar
  3. Berendsen HHG, Jenck F, Broekkamp CLE (1990) Involvement of 5-HT1C-receptors in drug-induced penile erections in rats. Psychopharmacology 101:57–61Google Scholar
  4. Closse A, Frick W, Markstein R, Maurer R, Nordmann R (1985) [3H] SDZ 205–501, a non-catechol dopaminergic agonist, labels selectively and with high affinity dopamine D2 receptors. J Neural Transm 62:231–248CrossRefPubMedGoogle Scholar
  5. Costentin J, Protais P, Schwartz JC (1975) Rapid and dissociated changes in sensitivities of different dopamine receptors in mouse brain. Nature 66:207–215Google Scholar
  6. Dubuc I, Protais P, Colboc O, Costentin J (1982) Antagonism of the apomorphine-induced yawning by “atypical” neuroleptics. Neuropharmacology 21:1203–1206CrossRefPubMedGoogle Scholar
  7. Hamon M (1991) 5-HT1 receptor subtypes — pharmacological heterogeneity. Abstracts of International Academy for Biomedical and Drug Research, Montecarlo, Principauté de Monaco, June 1991Google Scholar
  8. Lanfumey L, Haj-Dahmane S, Gozlan H, Fattaccini CM, Guillaumet G, Guardiola B, Hamon M 5-HT1A agonist properties of the two enantiomers of a new chroman derivative S-20244. Poster 3 (Serotonin 91 — Birmingham — 14–17th July 91)Google Scholar
  9. Middlemiss DN, Fozard JR (1983) 8-Hydroxy-2-(di-n-propylamino)-tetralin discriminates between sub-types of the 5-HT1 recognition site. Eur J Pharmacol 90:150–153CrossRefGoogle Scholar
  10. Moore NA, Sanger G, Rees G (1991) The roles of D2 dopamine receptors in 8-OH-DPAT-induced hypothermia in the mouse. Poster 60 (Serotonin 91 — Birmingham — 14–17th July 91).Google Scholar
  11. New JS (1990) The discovery and development of buspirone: a new approach to the treatment of anxiety. Med Res Rev 103:283–326Google Scholar
  12. Peroutka SJ (1985) Selective interaction of novel anxiolytics with 5-Hydroxytryptamine 1A receptors. Biol Psychiatry 20:971–979CrossRefPubMedGoogle Scholar
  13. Protais P, Dubuc I, Costentin J (1983) Pharmacological characteristics of dopamine receptors involved in the dual effect of dopamine agonists on yawning behavior in rats. Eur J Pharmacol 94:271–280CrossRefPubMedGoogle Scholar
  14. Urba-Holmgren R, Gonzales RM, Holmgren B (1977) Is yawning a cholinergic response? Nature 267:261–262CrossRefPubMedGoogle Scholar
  15. Yamada K, Furukawa T (1980) Direct evidence for involvement of dopaminergic inhibition and cholinergic activation in yawning. Psychopharmacology 67:39–43CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 1992

Authors and Affiliations

  • P. Simon
    • 1
  • B. Guardiola
    • 2
  • J. Bizot-Espiard
    • 2
  • P. Schiavi
    • 2
  • J. Costentin
    • 1
  1. 1.Unité de NeuropsychopharmacologieU.R.A. 1170 du C.N.R.S., Faculté de Médecine et Pharmacie de RouenSaint Etienne du RouvrayFrance
  2. 2.Iris-ServierCourbevoieFrance

Personalised recommendations